v1
Warfarin therapy is feasible in CYP2C9*3 homozygous patients.
Identifier:nobleid.org/w1/20260515/320FD326
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →